Biopharma Daily Stock Updates - 04/30/21

Apr 30, 20211 min read

$XBI $137 -1%

$SYGGF -19% Ph 2 covid data. source

$BTNX +5% & $PFE Request CMA in EU expansion to ages 12 to 15. source

$AZN +3% Farxgiga approved in US for CKD. source

$BCRX -4% Orladeyo EU approval for hereditary angioedema. source

$PRAX -5% PRAX-562 receives Orphan Drug designation for treatment of SCN2A-DEE. source

$SCYX +3% Ph 3 data presented at ACOG conference. source